Aura Biosciences: Momentum Meets Clinical Optionality - A Mid-Term Trade Setup
Aura Biosciences is trading near a 52-week high after a cash raise and steady clinical progress for belzupacap sarotalocan (bel-sar / AU-011). The company has runway into early 2027, a tighter float and improving technicals. This note lays out a mid-term (45 trading days) trade idea: a tactical long with specific entry, stop and target, and a balan…